Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 26;11(1):11085.
doi: 10.1038/s41598-021-90482-2.

Ocular findings among patients surviving COVID-19

Affiliations

Ocular findings among patients surviving COVID-19

Ílen Ferreira Costa et al. Sci Rep. .

Abstract

To describe the medium-term ophthalmological findings in patients recovering from COVID-19. Patients recovered from the acute phase of COVID-19 underwent a complete ophthalmological evaluation, including presenting and best-corrected visual acuity (BCVA), refractometry, biomicroscopy, tonometry, break-up time and Schirmer tests, indirect ophthalmoscopy, color fundus picture, and retinal architecture evaluation using optical coherence tomography. Socio-demographic data and personal medical history were also collected. According to the severity of systemic manifestations, patients were classified into mild-to-moderate, severe, and critical. Sixty-four patients (128 eyes) were evaluated 82 ± 36.4 days after the onset of COVID's symptoms. The mean ± SD duration of hospitalization was 15.0 ± 10.7 days. Seven patients (10.9%) had mild-to-moderate, 33 (51.5%) severe, and 24 (37.5%) critical disease. Median [interquartile ranges (IQR)] presenting visual acuity was 0.1 (0-0.2) and BCVA 0 (0-0.1). Anterior segment biomicroscopy was unremarkable, except for dry eye disease, verified in 10.9% of them. The mean ± SD intraocular pressure (IOP) in critical group (14.16 ± 1.88 mmHg) was significantly higher than in severe group (12.51 ± 2.40 mmHg), both in the right (p 0.02) and left eyes (p 0.038). Among all, 15.6% had diabetic retinopathy, and two patients presented with discrete white-yellowish dots in the posterior pole, leading to hyporreflective changes at retinal pigment epithelium level, outer segment, and ellipsoid layers. The present study identified higher IOP among critical cases, when compared to severe cases, and discrete outer retina changes 80 days after COVID-19 infection. No sign of uveitis was found.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Ocular Fundus multimodal imaging of a 48-year-old man (critical case) 128 days after first symptoms of COVID-19. Color fundus pictures of both eyes showing white-yellowish dots (arrows). Midphase fluorescein angiography pictures of the RE (middle left) and LE (middle right) showing transmission hyperfluorescence in the retina lesions 195 days after first symptoms of COVID-19. Optical coherence tomography (OCT) of the right eye shows hyporreflectivity in the retinal pigment epithelium and ellipsoid layers, and discontinuation of photoreceptors’ outer segments (arrow). (Fig. 1 is composed of six individual photographs, using the Microsoft® PowerPoint for Mac software, version 16.47 (21,031,401), author IFC).

References

    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157–160. doi: 10.23750/abm.v91i1.9397. - DOI - PMC - PubMed
    1. Petersen E, et al. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak. Int. J. Infect. Dis. 2020;93:205–207. doi: 10.1016/j.ijid.2020.02.052. - DOI - PMC - PubMed
    1. Zhou Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127:982–983. doi: 10.1016/j.ophtha.2020.04.028. - DOI - PMC - PubMed
    1. Inomata T, et al. Clinical and prodromal ocular symptoms in coronavirus disease: A systematic review and meta-analysis. Invest. Ophthalmol. Vis. Sci. 2020;61:29. doi: 10.1167/iovs.61.10.29. - DOI - PMC - PubMed
    1. Gangaputra SS, Patel SN. Ocular symptoms among nonhospitalized patients who underwent COVID-19 testing. Ophthalmology. 2020;127:1425–1427. doi: 10.1016/j.ophtha.2020.06.037. - DOI - PMC - PubMed

Publication types